Paxlovid is not an antibiotic. It is an antiviral medication designed specifically to treat COVID-19. This is a common point of confusion, since both drug types fight infections, but they work in fundamentally different ways against completely different targets.
How Antivirals and Antibiotics Differ
Antibiotics kill bacteria or block the processes bacteria need to survive and grow. They have no effect on viruses. Antivirals, on the other hand, stop a virus from making copies of itself or prevent it from entering and leaving cells. These are two entirely separate categories of medicine targeting two entirely separate types of organism.
This distinction matters in practice. Taking an antibiotic for a viral infection like COVID-19 won’t help, and unnecessary antibiotic use contributes to drug resistance. Early in the pandemic, nearly 60% of hospitalized COVID patients received antibacterial drugs on admission, yet only about 3.5% actually had a bacterial co-infection. Paxlovid exists to fill the gap that antibiotics cannot: treating the virus itself.
What Paxlovid Is and How It Works
Paxlovid is a combination of two drugs taken together as pills. The first, nirmatrelvir, directly attacks the SARS-CoV-2 virus by blocking an enzyme the virus needs to reproduce. Think of this enzyme as a pair of molecular scissors the virus uses to cut apart long protein chains into the smaller functional pieces it needs to assemble new copies of itself. Nirmatrelvir jams those scissors by binding to their active site, halting viral replication.
The second component, ritonavir, doesn’t fight the virus directly. Its job is to slow your liver from breaking down nirmatrelvir too quickly. Without ritonavir, nirmatrelvir would be metabolized before it could reach effective levels in your body. Ritonavir keeps nirmatrelvir circulating long enough to do its work. This “booster” approach was originally developed for HIV treatment and has been adapted here for COVID-19.
Who It’s Approved For
The FDA approved Paxlovid in 2023 for treating mild-to-moderate COVID-19 in adults who are at high risk for progressing to severe illness, hospitalization, or death. It is not approved for preventing COVID-19 before or after exposure.
In a large CDC analysis of U.S. adults diagnosed with COVID-19 (including those who had been vaccinated or previously infected), people who took Paxlovid within five days of diagnosis had a 51% lower hospitalization rate over the following 30 days compared to those who did not take it. Death rates were also significantly lower: 0.01% among those who received Paxlovid versus 0.04% among those who did not.
Timing and Treatment Course
Paxlovid is taken twice daily for five days. Treatment should start as soon as possible and within five days of symptom onset. Starting earlier generally gives better results, since the drug works by stopping viral replication during the window when viral load is highest and your immune system hasn’t yet mounted a full response. Once that early window closes, antiviral therapy becomes less effective.
One important consideration: because ritonavir affects how your liver processes many medications, Paxlovid can interact with a wide range of other drugs. If you take medications for heart conditions, seizures, blood clotting, or several other conditions, your prescriber will need to review potential interactions before starting treatment.
Why the Confusion Happens
People often reach for the word “antibiotic” as a catchall for any prescription that fights an infection. Respiratory illnesses have historically been treated with antibiotics (for bacterial pneumonia, strep throat, sinus infections), so it’s natural to assume a pill prescribed for a respiratory illness like COVID-19 falls into the same category. But COVID-19 is caused by a virus, not bacteria, and Paxlovid targets viral machinery that bacteria don’t have.
In some cases, a bacterial infection can develop alongside or after a COVID-19 infection. Bacterial pneumonia, for example, can sometimes occur as a secondary complication. In those situations, a doctor might prescribe an actual antibiotic to treat the bacterial component separately. But that antibiotic would be treating the bacterial problem, not the virus, and Paxlovid would be treating the virus, not the bacteria. The two serve completely different roles.